Characterization and Identification of Aptamers against CD49c for the Detection, Capture, and Release of Cancer Cells

ACS Appl Bio Mater. 2022 Jul 18;5(7):3461-3468. doi: 10.1021/acsabm.2c00389. Epub 2022 Jul 6.

Abstract

As a kind of recognition molecule, aptamers can be inserted into some regulatory sequences for the smart response of their targets. However, the molecular engineering might lead to the change of the binding affinity. Here, we present a stable aptamer ZAJ-2c and an environmentally sensitive aptamer ZAJ-2d optimized from an original cell-binding aptamer ZAJ-2, and the molecular target was further identified as CD49c on the cell membrane. ZAJ-2c was characterized with high binding ability independent of the presence of divalent cations at a temperature range from 4 to 37 °C, showing promise for measuring the expression of CD49c on cancer cells. Moreover, ZAJ-2d had a nanomolar binding affinity in the binding buffer at 4 °C, the same as ZAJ-2c, but lost the binding ability in a PBS buffer supplemented with 5 mM EDTA at 37 °C. This aptamer variant proved to selectively capture and release the CD49c positive cells by simply adjusting the temperatures and divalent cations. This set of aptamers might provide a toolbox for monitoring and operating of a wide range of cancer cells with CD49c expression on the surface, which will be helpful for the studying the heterogeneity of rare cells.

Keywords: CD49c; aptamer; biomarker; cancer cells; capture and release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aptamers, Nucleotide* / chemistry
  • Cations, Divalent
  • Integrin alpha3
  • Neoplasms*
  • SELEX Aptamer Technique

Substances

  • Aptamers, Nucleotide
  • Cations, Divalent
  • Integrin alpha3